Detalles de la búsqueda
1.
DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
J Virol
; 96(13): e0058522, 2022 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862693
2.
Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.
J Viral Hepat
; 29(9): 765-776, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718996
3.
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 study.
J Viral Hepat
; 29(6): 455-464, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080256
4.
Efficacy and safety of direct-acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real-world study in Guangdong, China.
J Med Virol
; 94(9): 4459-4469, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545872
5.
Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis.
J Med Virol
; 93(4): 2505-2512, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33433006
6.
Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19.
Int J Med Sci
; 18(1): 29-41, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33390771
7.
Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis.
J Viral Hepat
; 27(1): 45-51, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520460
8.
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial.
Liver Int
; 40(11): 2685-2693, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047868
9.
Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B.
J Viral Hepat
; 26 Suppl 1: 77-84, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31380586
10.
A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum.
Arch Virol
; 164(11): 2683-2690, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428915
11.
A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection.
Clin Infect Dis
; 66(1): 29-35, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020289
12.
Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway.
Mediators Inflamm
; 2015: 508989, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26060358
13.
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.
Infect Dis Ther
; 12(11): 2595-2609, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856013
14.
[Study on the copy numbers and mRNA expression levels of the programmed death-1 gene in chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 19(9): 678-82, 2011 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-22152383
15.
Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients.
Virus Res
; 302: 198453, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991622
16.
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China.
J Clin Virol
; 133: 104661, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33096290
17.
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
Med
; 1(1): 105-113.e4, 2020 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32838353
18.
Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19.
Nat Med
; 26(9): 1491-1493, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770170
19.
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
Cell Mol Immunol
; 17(11): 1119-1125, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33037400
20.
Temporal dynamics in viral shedding and transmissibility of COVID-19.
Nat Med
; 26(5): 672-675, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32296168